3.237.34.21
dgid:
enl:
npi:0
-Advertisement-
-Advertisement-

Industry News

Thea Pharma Inc launches preservative-free latanoprost ophthalmic solution in the U.S.

Thea Pharma Inc has launched Iyuzeh (latanoprost ophthalmic solution) 0.005% to the U.S. market, according to a press release. This preservative-free latanoprost, previously launched over a decade ago and used by around 1.5 million patients monthly across 46 countries under the brand Monoprost, is now available in the U.S. Iyuzeh...

Read More
-Advertisement-
-Advertisement-
-Advertisement-
-Advertisement-
-Advertisement-
-Advertisement-
-Advertisement-
-Advertisement-
-Advertisement-
-Advertisement-
-Advertisement-